CD146+ cells selected from human heterogenous AD-MSCs exhibited more beneficial angiogenic and adipogenic properties [110], confirming benefits in reconstructive and tissue engineering applications for AD-MSC-CD146+ cells. The gene discussed is MCAM; the disease is Alzheimer disease.